Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas

Laboratory Investigation

Volumn 80, Issue 5, 2000, Pages 689-695

  Shim, Yhong Hee ^a,b   Kang, Gyeong Hoon ^a   Ro, Jae Y ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ARTICLE; CHROMOSOME 9P; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE FREQUENCY; GENE INACTIVATION; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; STOMACH CARCINOMA;

EID: 0342748644     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780072     Document Type: Article

References (26)

1. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR, Baylin SB, and Issa J-P (1997). Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 57:3370-3374.
2. Akama Y, Yashui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T, and Tahara E (1996). Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res 87: 824-830.
3. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi Y-Q, Rhyu M-G, Powell SM, James SP, Wilson KT, Herman JG, and Meltzer SJ (1999). Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59:1090-1095.
4. Foster SA, Wong DJ, Barrett MT, and Galloway DA (1998). Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 18:1793-1801.
5. Gunther TH, Schneuder-Stock R, Pross M, Manger T, Malfertheiner P, Lippert H, and Roessner A (1998). Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer. Pathol Res Pract 194:809-813.
6. Herman JG, Graff JR, Myohanen S, Nelkin BD, and Baylin SB (1996). Methylation-specific PCR: A novel PCR assay for methylation status of CpG islans. Proc Natl Acad Sci USA 93:9821-9826.
7. Herman JG, Merio A, Mao L, Lapidus RG, Issa J-P, Davidson NE, Sidransky D, and Baylin SB (1995). Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4524-4530.
8. Hsieh C-L (1994). Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 14:5487-5494.
9. INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58:3942-3945.
10. Igaki H, Sadaki H, Tachimori Y, Kato H, Watanabe H, Kimura T, Harada Y, Sugimura T, and Terada M (1995). Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res 55:3421-3423.
11. Kamb A (1995). Cell-cycle regulators and cancer. Trends Genet 11:136-140.
12. Kang GH, Shim YH, and Ro JY (1999a). Correlation of methylation of the hMLH1 promoter with lack of expression of hMNL1 in sporadic gastric carcinomas with replication error. Lab Invest 79:903-909.
13. Kang GH, Yoon GS, Lee HK, Kwon YM, and Ro JY (1999b). Clinicopathologic characteristics of replication error-positive gastric carcinoma. Mod Pathol 12:15-20.
14. Lee YY, Kang SH, Seo JY, Jung CW, Lee KU, Choe KJ, Kim BK, Kim NK, Koeffler HP, and Bang Y-J (1997). Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer 80:1889-1896.
15. Leung SY, Yuen ST, Chung LP, Chu KM, Chan ASY, and Ho JCI (1999). hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59:159-164.
16. Liew CT, Li H-M, Lo K-W, Leow CK, Chan JYH, Hin LY, Lau WY, Lai PBS, Lim BK, Huang J, Leung WT, Wu S, and Lee JCK (1999). High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 18:789-795.
17. Liggett WH and Sidransky D (1998). Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 16:1197-1206.
18. Matsuda Y, Ichida T, Matsuzawa J, Sungimura K, and Asakura H (1999). P16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116:394-400.
19. Myohanen SK, Baylin SB, and Herman JG (1998). Hypermethylation can selectively silence individual p16INK4A alleles in neoplasia. Cancer Res 58:591-593.
20. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, and Herman JG (1997). Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57:3126-3130.
21. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, and Imai K (1999). Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83:309-313.
22. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, and Issa J-P (1999a). CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96:8681-8686.
23. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, and Issa J-P (1999b). Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59:5438-5442.
24. Vasen HFA, Mecklin J-P, Khan PM, and Lynch HT (1991). The international collaborative group on hereditary non-polyposis colorectal cancer. Dis Colon Rectum 34:424-425.
25. Wu M-S, Lin Y-W, Sheu J-C, Wang H-P, Wang J-T, Shun C-T, Lee W-J, Wang T-H, and Lin J-T (1996). Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan. Jpn J Cancer Res 87:1052-1055.
26. Wu M-S, Shun C-T, Sheu J-C, Wang H-P, Wang J-T, Lee W-J, Chen C-J, Wang T-H, and Lin J-T (1998). Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: With respect to histological subtypes and stages. J Gastroenterol Hepatol 13:305-310.